MVM Life Science Partners has closed a $233 million fourth fund to invest in technologies, therapeutics, medical devices and healthcare IT companies. The London-based firm expects to do deals ranging from early stage to public companies. It will invest about $15 million to $30 million per portfolio company. Its med tech investments have included surgical wound closure company ZipLine Medical, noninvasive hemodynamic monitoring company Cheetah Medical and AAA stent graft manufacturer Lombard Medical Technologies ($EVAR). More